World Summit on COVID-19 (Part V)
  • Follow

SciTech Central COVID-19 

World Summit on COVID-19 (Part V)

Virtual Seminar 

July 06-07, 2022

Register Now
Past COVID-19 Seminar

World Summit on COVID-19 (Part V)

After a successful completion of Global Summit on COVID-19 during December 14-15, 2021, we are initiating SciTech Central COVID-19 (World Summit on COVID-19 (Part V)) is a 2 days seminar scheduled on July 06-07, 2022 under the theme "New Aspects of COVID-19 and it's Challenges". The interested speakers are requested to submit abstract and pre-recorded video of the talk. Speakers can be academicians, researchers, scientists, students, faculty members, healthcare executives, doctors etc. The exhibitors are invited to promote their healthcare products at our conference websites.

Corona virus is an infectious virus causing mild to severe respiratory illness in humans. The first case of corona virus or COVID-19 was first reported in Wuhan, China in December 2019. Since then the virus has spread to all continents and to whole world. The virus enters your body through the mouth, nose, eyes (the airborne droplets or from transfer of the virus from hands to face). Corona viruses are found in bats, cats and camels too. Eventually, the virus can spread from animal species and begins to infect humans. It is good to make habit of doing hygienic practices, like by coughing into a flexed elbow, throughing the used masks and tissues, staying at home and self-isolating until recovery if the person feels unwell. 

Remdesivir is a drug given intravenously to treat hospitalized patients with COVID-19 infection. If the patient is not hospitalized or don’t need supplemental oxygen, no specific antiviral or immunotherapy is recommended. Some people may also present good prognosis from an infusion of monoclonal antibodies. But if the patient is in the hospital, he may be given IV Remdesivir with or without the oral corticosteroid dexamethasone (or another steroid) or dexamethasone alone if remdesivir cannot be used. It is highly encouraging to see so many people getting vaccinated and going in to development. Being vaccinated does not mean that we are safe and can travel anywhere and put ourselves and others at risk. For the foreseeable future and to prevent reoccurrence of the virus, we must continue wearing masks, cleaning our hands, ensuring good ventilation indoors, physically distancing and avoiding crowds.

For Past COVID-19 Conferences: Click Here            For Abstract Submission: Click Here                

Discussions on: 
  • COVID-19 vaccination in United States, UK, India, Italy, Australia, Japan etc
  • Black fungus and its effects
  • Efficacy of COVID 19 vaccination on the symptoms of long COVID
  • Nano and Biosensors for detection of SARS CoV-2
  • Variants of corona virus and their potency
  • Corona virus and cancer patients
  • Covid Pneumonia and diabetes emergencies
  • Bell’s palsy triggered by corona virus
  • COVID -19 Associated Nephropathy
  • Gullian Barre Syndrome associated with COVID-19 vaccination
  • Effectiveness of Plasmapheresis in critically ill corona patients
  • Social isolation in COVID-19 and mental health
  • Elevated plasmin and Covid susceptibility
  • COVID-19 and lessons learned from past epidemics
  • CT imaging in COVID-19 Pneumonia
  • Corona virus in pregnancy and delivery
  • Corticosteroids in management of pregnant women with COVID-19
  • Financial crisis during COVID-19 pandemic
  • Effect of COVID-19 on educational system
  • Covid vaccine principles and challenges in delivery and development
  • Mucurmycosis and post Covid side effects
  • Pollution vs. pandemic effects
  • Impact of COVID-19 on health care workers
  • Plight of migrants during Covid pandemic
  • COVID-19 impact on vulnerable groups
  • Negative impact of COVID-19 on students
  • Efficacy of physiotherapy in Covid patients
  • Cough suppression techniques in Covid patients
  • Pfizer-BioNTech vaccine for vulnerable children
  • Genetics in COVID-19 Treatment
  • Efficacy and safety of Remdesivir
  • Practice of preventive measures against COVID-19
  • Role of medicinal plants in Covid treatment
  • Secondary infection in recovered COVID-19 patients
  • Herd Immunity against SARS-CoV-2
  • Impact of Hydroxychloroquine Treatment of COVID-19
  • Infectivity Mechanism of SARS-CoV-2 and Its Variants
  • Neutralisation of omicron variant of the SARS-CoV-2
  • Analysis of booster vaccine to reduce SARS-CoV-2 Infection
  • Resistance against the monoclonal antibodies of Covaxin
  • Sputnik V efficiency against Delta Variant

Accepted Abstracts

Associated Journals


Abstract Due Date : June 30, 2022
Registration Closes : July 05, 2022

Register your interest to keep up to date with the latest information.